Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease

Annali dell'Istituto Superiore di Sanita

Volumn 41, Issue 2, 2005, Pages 197-203

  Bocca, Beatrice ^a   Forte, Giovanni ^a   Petrucci, Francesco ^a   Pino, Anna ^a   Marchione, Francesca ^b   Bomboi, Giuseppe ^b   Senofonte, Oreste ^a   Giubilei, Franco ^b   Alimonti, Alessandro ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alzheimer's disease; Metals; Oxidative status; Serum; Whole blood

Indexed keywords

ALUMINUM; CADMIUM; CALCIUM; COBALT; COPPER; HYDROPEROXIDE; HYPOCHLORITE; IRON; LEAD; LIPID PEROXIDE; LITHIUM; MAGNESIUM; MANGANESE; MERCURY; MOLYBDENUM; SILICON; TIN; TRACE ELEMENT; ZINC; ZIRCONIUM;

AEROBIC METABOLISM; AGED; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BIOLOGICAL MONITORING; BLOOD LEVEL; BODY FLUID; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NEUROTOXICITY; OXIDATIVE STRESS; PATHOGENESIS; QUANTITATIVE ANALYSIS; SERUM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDES; MALE; MASS SPECTROMETRY; METALS; MIDDLE AGED; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; SILICON; SPECIMEN HANDLING;

EID: 31644448061     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr 2000;71:621S-9S.
2. Behl C. Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res 1997;290:471-80.
3. Bush AI. Copper, zinc, and the metallobiology of Alzheimer disease. Alz Dis Assoc Dis 2003;17(3):147-50.
4. Atwood CS, Huang X, Moir RD, Tanzi RE, Bush AI. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. Met Ions Biol Syst 1999;36:309-64.
5. Finefrock AE, Bush AI, Murali Doraiswamy P. Current status of metals as therapeutic targets in Alzheimer's disease. J Am Ger Soc 2003;51:1143-48.
6. Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. Redox-active metals, oxidative stress, and Alzheimer's Disease pathology. Ann NY Acad Sci 2004;1012:153-63.
7. Good PF, Perl DP, Bierer LM, Schemeidler J. Selective accumulation of aluminium and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol 1992;31:286-92.
8. Ward NI, Mason JA. Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease. J Radioanal Nucl Ch 1987;113(2):515-26.
9. Flaten TP. Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Res Bul 2001;55(2):187-96.
10. Rondeau V, Commenges D, Jacqmin-Gadda H, Dartigues JF. Relations between aluminium concentrations in drinking water and Alzheimer's disease. Am J Epidemiol 2000;152(1):59-66.
11. Zatta P, Lucchini R, Van Rensburg SJ, Taylor A. The role of metals in neurodegenerative processes: aluminium, manganese and zinc. Brain Res Bul 2003;62:15-28.
12. Plantin LO, Lying-Tunell U, Kristensson K. Trace elements in the human central nervous system studied with neutron activation analysis. Biol Trace Elem Res 1987;13:69-75.
13. Andrási E, Farkas É, Scheibler H, Réffy A, Bezúr L. Al, Zn, Cu, Mn and Fe levels in brain in Alzheimer's disease. Arch Gerontol Geriat 1995;21:89-97.
14. Yasui M, Kihira T, Ota K. Calcium, magnesium and aluminium concentrations in Parkinson's disease. Neurotoxicology 1992;13:593-600.
15. Brzyska M, Elbaum D. Dysregulation of calcium in Alzheimer's disease. Acta Neurobiol Exp 2003;63:171-83.
16. Glick JL. Use of magnesium in the management of dementias. Med Sci Res 1990;18:831-33.
17. Thompson CM, Markesbery WR, Ehmann WD, Mao Y-X, Vance DE. Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology 1988;9:1-8.
18. Wenstrup D, Ehmenn WD, Markesbery WR. Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brain. Brain Res 1990;533:125-31.
19. Yun SW, Hoyer S. Effects of low-level lead on glycolytic enzymes and pyruvate dehydrogenase of rat brain in vitro: relevance to sporadic Alzheimer's disease? J Neural Transm 2000;107:355-68.
20. Birchall JD, Chappell JS. The chemistry of aluminium and silicon in relation to Alzheimer's disease. Clin Chem 1988;34:265-7.
21. Patra RC, Swarp D, Senapati SK. Effect of cadmium on lipid peroxides and superoxide dimutasein hepatic renal and testicular tissue of rats. Vet Hum Toxicol 1999;41(2):65-7.
22. Panayi AE, Spyrou NM, Iversen BS, White MA, Part P. Determination of cadmium and zinc in Alzheimer's brain tissue using Inductively Coupled Plasma Mass Spectrometry. J Neurol Sci 2002;195:1-10.
23. Bocca B, Alimonti A, Petrucci F, Violante N, Sancesario G, Forte G, Senofonte O. Quantification of trace elements by sector field inductively coupled plasma mass spectrometry in urine, serum, blood and cerebrospinal fluid of patients with Parkinson's disease. Spectrochim Acta B 2004;59:559-66.
24. Bocca B, Alimonti A, Petrucci F, Senofonte O, Violante N, Forte G. Development of methods for the quantification of essential and toxic elements in human biomonitoring. Ann Ist Super Sanità 2005;41(2):165-70.
25. Lucchini R, Albini E, Cortesi I, Placidi D, Bergamaschi E, Traversa F, Alessio L. Assessment of neurobehavioral performance as a function of current and cumulative occupational lead exposure. Neurotoxicology 2000;21(5):805-12.
26. Kamel F, Umbach DM, Munsat TL, Shefner JM, Hu H, Sandler DP. Lead exposure and amyotrophic lateral sclerosis. Epidemiol 2002;13(3):311-9.
27. Basun H, Forssell LG, Wetterberg L, Winblad B. Metals and trace elements in plasma and cerebrospinal fluid in normal ageing and Alzheimer's disease. J Neural Transm (P-D Sect) 1991;4:231-58.
28. Emard JF, Thouez JP, Gauvreau D. Neurodegenerative diseases and risk factors: a literature review. Soc Sci Med 1995;40(6): 847-58.
29. Olivieri G, Hess C, Savaskan E, Ly C, Meier F, Baysang G, Brockhaus M, Müller-Spann F. Melatonin protects SHSY5Y neuroblastoma cells from cobalt-induced oxidative stress, neurotoxicity and increased β-amyloid secretion. J Pineal Res 2001;31:320-325.
30. Hock C, Drasch G, Golombowski S, Müller-Spann F, Willershausen-Zönnchen B, Schwarz P, Hock U, Growdon JH, Nitsch RM. Increased blood mercury levels in patients with Alzheimer's disease. J Neural Transm 1998;105:59-68.
31. Fung YK, Mead AG, Rack EP, Blotcky AJ, Claassen JP, Beatty MW, Durham T. Determination of blood mercury concentrations in Alzheimer's disease. Clin Toxicol 1995;33:243-7.
32. Flaten TP, Alfrey AC, Birchall JD, Savory J, Yokel RA. Status and future concerns of clinical and environmental aluminium toxicology. In: Yokel RA, Golub MS (Ed). Research Issues in Aluminum Toxicity. Washington: Taylor and Francis; 1997. p. 1-15.
33. Ferner IN, Leake A, Taylor GA, McKeith IG, Fairbairn AF, Robinson CJ, Francis RM, Edwardson JA. Reduced gastrointestinal absorption of calcium in dementia. Age ageing 1990;19:368-75.
34. Jagannatha Rao KS, Shanmugavelu P, Shankar SK, Rukmini Devi RP, Rao RV, Pande S, Menon RB. Trace elements in the cerebrospinal fluid in Alzheimer's disease. Alz Rep 1999;2:333-8.
35. McMillan DE. A brief history of the neurobehavioral toxicity of manganese: some unanswered questions. Neurotoxicology 1999;20:499-507.
36. Liccione JJ, Maines MD. Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese. J Pharm Exp Ther 1988;247:156-61.
37. Sloot WN, Korf J, Koster JF, Dewit LEA, Gramsbergen JBP. Manganese-induced hydroxyl radical formation in rat striatum is not attenuated by dopamine depletion or iron chelation in vivo. Exp Neurol 1996;138:236-45.
38. Molina JA, Jiménez-Jiménez FJ, Aguilar MV, Meseguer I, Mateos-Vega C, Gonzáles-Muñoz MJ, de Bustos F, Porta J, Ortí-Pareja M, Zurdo M, Barrios E, Martínez-Para MC. Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm 1998;105:479-88.
39. Pamphlett R, McQuilty R, Zarkos K. Blood levels of toxic and essential metals in motor neuron disease. Neurotoxicology 2001;22:401-10.
40. Jeandel C, Nicolas MB, Dubois F, Nabet-Belleville F, Penin F, Cuny G. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 1989;35(5-6):275-82.
41. Ripova D, Platilova V, Strunecka A, Jirak R, Hoschl C. Alterations in calcium homeostasis as biological marker for mild Alzheimer's disease? Physiol Res 2004;53:449-52.
42. Hershey L, Hershey C, Varnes AW, CSF silicon in dementia: a prospective study, Neurology 1984;34:1197-201.
43. Squitti R, Lupoi D, Pasqualetti P, Dal Forno G, Verzieri F, Chiovenda P, Rossi L, Cortesi M, Cassetta E, Rossigni PM. Elevation of serum copper levels in Alzheimer's disease. Neurology 2002;59:1153-61.